Medical imaging Artificial Intelligence (AI) companies are growing in number and struggle to gain access to anonymized image data sets to train the AI algorithms. The AI companies have typically contracted with individual health systems to gain access to their data, but that introduces regional bias and scalability issues. Would you consider participating in a marketplace concept to sell your anonymized images? What operational, financial, regulatory, and political factors may be in play for you to consider this?

Laura Brown MS, PA-C, WCC, DWC,
Chief Clinical Officer,
ImageMover

Kevin Houlihan MBA,
CEO,
ImageMover